BIOTECHNOLOGY VALUE FUND L P - 01 Jul 2025 SCHEDULE 13G Report for NEKTAR THERAPEUTICS Common Stock, $0.0001 par value (NKTR)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
NEKTAR THERAPEUTICS Common Stock, $0.0001 par value
Symbol
NKTR
Shares outstanding
17,251,284 shares
Disclosed Ownership
1,276,595 shares
Ownership
7.4%
Form type
SCHEDULE 13G
Filing time
09 Jul 2025, 16:39:22 UTC
Date of event
01 Jul 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 3.8% 661,758 0 661,758 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 3.8% 661,758 0 661,758 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3% 517,813 0 517,813 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3% 517,813 0 517,813 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 71,367 0 71,367 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 71,367 0 71,367 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 6.8% 1,179,571 0 1,179,571 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 7.4% 1,276,595 0 1,276,595 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 7.4% 1,276,595 0 1,276,595 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 7.4% 1,276,595 0 1,276,595 /s/ Mark N. Lampert Mark N. Lampert